Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.

International journal of oncology - 1 Apr 2009

Charpin Colette, Giusiano Sophie, Secq Véronique, Carpentier Séverine, Andrac Lucile, Lavaut Marie-Noëlle, Allasia Claude, Bonnier Pascal, Garcia Stéphane

Abstract excerpt

We aimed in this study at identifying prognostic immunohistochemical molecular signatures indicative of disease outcome, also relevant for development of new specific therapies, in triple-negative (ER, PR, c-erbB2- negative) breast carcinoma subtypes. We evaluated 42 markers in tissue micro-arrays from a series of 924 breast carcinomas including 184 triple-negative tumors using standardized quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Carcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasm Metastasis

Share to Recurrence

Share to Regression Analysis

Share to ROC Curve

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 19287955
DOI: 10.3892/ijo_00000224

Genes

EGFR
PTEN
STAT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.PMID 19287955Read ↗

Functional Proteomic Profiling of Triple-Negative Breast CancerSemantic proximity Read ↗

Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.Semantic proximity Read ↗

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancerSemantic proximity Read ↗

Prognostic markers in triple-negative breast cancer.Semantic proximity Read ↗

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.Semantic proximity Read ↗

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.Semantic proximity Read ↗

High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer PatientsSemantic proximity Read ↗

Tissue microarrays for comparing molecular features with proliferation activity in breast cancerSemantic proximity Read ↗

[Immunohistochemical characterisation of breast cancer: towards a new clasification?].Semantic proximity Read ↗

Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.Semantic proximity Read ↗

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.Semantic proximity Read ↗

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.